2-Bromo-3-methoxycyclopent-2-enone

Catalog No. :
ACQIUB328
CAS No. :
14203-25-9
Molecular Formula :
C6H7BrO2
Molecular Weight :
191.02

IUPAC Name:2-bromo-3-methoxycyclopent-2-en-1-one

2-Bromo-3-methoxycyclopent-2-enone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$117.00Login to see priceInquiryInquiry
250mg97%$176.00Login to see priceInquiryInquiry
1g97%$282.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-3-methoxycyclopent-2-enone
IUPAC Name2-bromo-3-methoxycyclopent-2-en-1-one
MDL No.MFCD11044009
Molecular FormulaC6H7BrO2
Molecular Weight191.02
SMILESCOC(CC1)=C(Br)C1=O
InChI KeyRKDVAJMYDPQTFK-UHFFFAOYSA-N
Synonym2-Cyclopenten-1-one, 2-bromo-3-methoxy- | FT-0731450 | P19034 | 2-bromo-3-(methyloxy)-2-cyclopenten-1-one | 2-bromo-3-methoxy-2-cyclopenten-1-one | DTXSID10455002 | PB40595 | MFCD11044009 | CS-0040747 | SY163225 | 2-bromo-3-methoxy-cyclopent-2-en-1-one |
CAS No.14203-25-9
PubChem CID11095426

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACQIUB328 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQIUB328 route product structure diagram
    ACQIUB32814203-25-9
Inquiry

2. ACQIUB328 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNCEB235 route compound structure diagram
    ACNCEB2354683-50-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQIUB328 route product structure diagram
    ACQIUB32814203-25-9
Inquiry

Comments (0)